Does clinical-CT 'mismatch' predict early response to treatment with recombinant tissue plasminogen activator?

John Y. Choi, Jennifer K. Pary, Andrei Alexandrov, Carlos A. Molina, Zsolt Garami, Marc Malkoff, Marta Rubiera, Hashem M. Shaltoni, Lemuel A. Moye, James C. Grotta

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: We hypothesized that patients with clinically severe strokes but less severe early ischemic changes on brain CT (i.e., clinical-CT mismatch) may respond better to intravenous recombinant tissue plasminogen activator (i.v. rt-PA) within 3 h of symptom onset. Methods: In this secondary analysis of the CLOTBUST data, patients with middle cerebral artery occlusions on transcranial Doppler (TCD) were treated with i.v. rt-PA. Alberta Stroke Program Early CT Scores were obtained with raters blinded to the NIH Stroke Scale and TCD results. Two mismatch criteria and three criteria of response to therapy were explored. Results: Of 126 patients, 67% had a mismatch type 1 and 74% had a mismatch type 2. The presence of clinical-CT mismatch by either definition did not correlate with any of the three criteria of response to rt-PA. Recanalization was a strong determinant of response, whether or not mismatch was present. Conclusions: Mismatch between severity of neurological deficit and CT findings is common but does not predict response to rt-PA therapy given within 3 h.

Original languageEnglish (US)
Pages (from-to)384-388
Number of pages5
JournalCerebrovascular Diseases
Volume22
Issue number5-6
DOIs
StatePublished - Oct 1 2006

Fingerprint

Tissue Plasminogen Activator
Stroke
Alberta
Middle Cerebral Artery Infarction
Therapeutics
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Does clinical-CT 'mismatch' predict early response to treatment with recombinant tissue plasminogen activator? / Choi, John Y.; Pary, Jennifer K.; Alexandrov, Andrei; Molina, Carlos A.; Garami, Zsolt; Malkoff, Marc; Rubiera, Marta; Shaltoni, Hashem M.; Moye, Lemuel A.; Grotta, James C.

In: Cerebrovascular Diseases, Vol. 22, No. 5-6, 01.10.2006, p. 384-388.

Research output: Contribution to journalArticle

Choi, JY, Pary, JK, Alexandrov, A, Molina, CA, Garami, Z, Malkoff, M, Rubiera, M, Shaltoni, HM, Moye, LA & Grotta, JC 2006, 'Does clinical-CT 'mismatch' predict early response to treatment with recombinant tissue plasminogen activator?', Cerebrovascular Diseases, vol. 22, no. 5-6, pp. 384-388. https://doi.org/10.1159/000094856
Choi, John Y. ; Pary, Jennifer K. ; Alexandrov, Andrei ; Molina, Carlos A. ; Garami, Zsolt ; Malkoff, Marc ; Rubiera, Marta ; Shaltoni, Hashem M. ; Moye, Lemuel A. ; Grotta, James C. / Does clinical-CT 'mismatch' predict early response to treatment with recombinant tissue plasminogen activator?. In: Cerebrovascular Diseases. 2006 ; Vol. 22, No. 5-6. pp. 384-388.
@article{440ae742390f4c1292ad420be6f0eee0,
title = "Does clinical-CT 'mismatch' predict early response to treatment with recombinant tissue plasminogen activator?",
abstract = "Background: We hypothesized that patients with clinically severe strokes but less severe early ischemic changes on brain CT (i.e., clinical-CT mismatch) may respond better to intravenous recombinant tissue plasminogen activator (i.v. rt-PA) within 3 h of symptom onset. Methods: In this secondary analysis of the CLOTBUST data, patients with middle cerebral artery occlusions on transcranial Doppler (TCD) were treated with i.v. rt-PA. Alberta Stroke Program Early CT Scores were obtained with raters blinded to the NIH Stroke Scale and TCD results. Two mismatch criteria and three criteria of response to therapy were explored. Results: Of 126 patients, 67{\%} had a mismatch type 1 and 74{\%} had a mismatch type 2. The presence of clinical-CT mismatch by either definition did not correlate with any of the three criteria of response to rt-PA. Recanalization was a strong determinant of response, whether or not mismatch was present. Conclusions: Mismatch between severity of neurological deficit and CT findings is common but does not predict response to rt-PA therapy given within 3 h.",
author = "Choi, {John Y.} and Pary, {Jennifer K.} and Andrei Alexandrov and Molina, {Carlos A.} and Zsolt Garami and Marc Malkoff and Marta Rubiera and Shaltoni, {Hashem M.} and Moye, {Lemuel A.} and Grotta, {James C.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1159/000094856",
language = "English (US)",
volume = "22",
pages = "384--388",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "5-6",

}

TY - JOUR

T1 - Does clinical-CT 'mismatch' predict early response to treatment with recombinant tissue plasminogen activator?

AU - Choi, John Y.

AU - Pary, Jennifer K.

AU - Alexandrov, Andrei

AU - Molina, Carlos A.

AU - Garami, Zsolt

AU - Malkoff, Marc

AU - Rubiera, Marta

AU - Shaltoni, Hashem M.

AU - Moye, Lemuel A.

AU - Grotta, James C.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Background: We hypothesized that patients with clinically severe strokes but less severe early ischemic changes on brain CT (i.e., clinical-CT mismatch) may respond better to intravenous recombinant tissue plasminogen activator (i.v. rt-PA) within 3 h of symptom onset. Methods: In this secondary analysis of the CLOTBUST data, patients with middle cerebral artery occlusions on transcranial Doppler (TCD) were treated with i.v. rt-PA. Alberta Stroke Program Early CT Scores were obtained with raters blinded to the NIH Stroke Scale and TCD results. Two mismatch criteria and three criteria of response to therapy were explored. Results: Of 126 patients, 67% had a mismatch type 1 and 74% had a mismatch type 2. The presence of clinical-CT mismatch by either definition did not correlate with any of the three criteria of response to rt-PA. Recanalization was a strong determinant of response, whether or not mismatch was present. Conclusions: Mismatch between severity of neurological deficit and CT findings is common but does not predict response to rt-PA therapy given within 3 h.

AB - Background: We hypothesized that patients with clinically severe strokes but less severe early ischemic changes on brain CT (i.e., clinical-CT mismatch) may respond better to intravenous recombinant tissue plasminogen activator (i.v. rt-PA) within 3 h of symptom onset. Methods: In this secondary analysis of the CLOTBUST data, patients with middle cerebral artery occlusions on transcranial Doppler (TCD) were treated with i.v. rt-PA. Alberta Stroke Program Early CT Scores were obtained with raters blinded to the NIH Stroke Scale and TCD results. Two mismatch criteria and three criteria of response to therapy were explored. Results: Of 126 patients, 67% had a mismatch type 1 and 74% had a mismatch type 2. The presence of clinical-CT mismatch by either definition did not correlate with any of the three criteria of response to rt-PA. Recanalization was a strong determinant of response, whether or not mismatch was present. Conclusions: Mismatch between severity of neurological deficit and CT findings is common but does not predict response to rt-PA therapy given within 3 h.

UR - http://www.scopus.com/inward/record.url?scp=33750594436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750594436&partnerID=8YFLogxK

U2 - 10.1159/000094856

DO - 10.1159/000094856

M3 - Article

C2 - 16888380

AN - SCOPUS:33750594436

VL - 22

SP - 384

EP - 388

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 5-6

ER -